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ABSTRACT
This study investigated whether the epidemiology of penicillin-non-susceptible pneumococci (PNSP)
colonising small children correlated with the biannual epidemic activity of respiratory syncytial virus
(RSV). Colonisation rates and the prevalence of PNSP among paediatric outpatients aged < 5 years was
analysed between January 1998 and September 2003 using an established national surveillance network.
Resistance trends were investigated using time-series analysis to assess the correlation with the biannual
pattern of RSV infections and national sales of oral paediatric formulations of antibiotics and antibiotic
prescriptions to children aged < 5 years for acute respiratory tract infections. PNSP rates exhibited a
biannual cycle in phase with the biannual seasonal RSV epidemics (p < 0.05). Resistance rates were
higher during the winter seasons of 1998–1999 (20.1%), 2000–2001 (16.0%) and 2002–2003 (19.1%),
compared with the winter seasons of 1997–1998 (8.2%), 1999–2000 (11.6%) and 2001–2002 (9.5%).
Antibiotic sales and prescriptions showed regular peaks during each winter, with no significant
correlation with the biannual pattern of RSV activity and seasonal trends of PNSP. RSV is an important
determinant of the spread of PNSP and must be considered in strategies aimed at antimicrobial
resistance control.
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INTRODUCTION
Streptococcus pneumoniae is one of the most
important human pathogens, and rising antibiotic
resistance rates among pneumococci worldwide
are a cause for concern. In temperate regions,
pneumococcal infections peak regularly during
the winter season, together with infections caused
by other respiratory pathogens, especially viruses
[1–4]. Pneumococcal resistance rates for b-lactam
antibiotics have also been shown to correspond
with disease activity cycles during winter in Spain
[5,6]. The potential for synergic activity between
respiratory viruses and bacteria in the nasophar-
ynx has been of interest for decades. A common
hypothesis is that cellular damage in the respir-
atory tract induced by viruses may facilitate the
invasion of pathogenic bacteria. There is now
increasing evidence for more specific interactions.
For example, respiratory syncytial virus (RSV)
infection can increase the adherence of S. pneu-
moniae [7], Neisseria meningitidis [8], Haemophilus
influenzae type b [9] and Bordetella pertussis [10] to
human epithelial cell lines. In a chinchilla model,
influenza A virus infection increased colonisation
of the nasopharynx with S. pneumoniae [11,12],
and adenovirus infection [13] enhanced colonisa-
tion with non-typable H. influenzae.
RSV is one of the most important viral res-
piratory pathogens, and is the most important
cause of hospitalisation of infants [14,15]. In
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Switzerland, RSV has shown a stable biannual
pattern of epidemic activity since at least the
1980s (K. Schopfer, personal communication) [15].
This pattern has also been reported from some
northern European countries [16–18]. The present
study investigated whether the carriage rate of
penicillin-non-susceptible pneumococci (PNSP) in
children aged < 5 years correlated with the
biannual activity of RSV.
MATERIALS AND METHODS
National trends in rates of nasopharyngeal colonisation with
S. pneumoniae and the prevalence of PNSP
Colonisation rates and the prevalence of PNSP were calculated
from data concerning nasopharyngeal isolates of S. pneumoniae
collected from outpatients aged < 5 years who presented with
acute otitis media or pneumonia within the Swiss Sentinel
Surveillance Network between January 1998 and September
2003 [19]. This surveillance system has been ongoing since
1998 with no major changes; however, because surveillance
was interrupted during the year 2000 for evaluation of the
system, no data were available for the year 2000. Susceptibility
testing was performed at the Institute for Infectious Diseases,
University of Bern, Switzerland, as described previously [19].
Data for RSV activity
The stable biannual cycling pattern of RSV activity was
documented for Switzerland on a national scale between
January 1988 and March 1999, when reporting of RSV
detection was mandatory [15]. In addition, surveillance for
the Bern region, based on hospitalisation data for RSV
infection, shows the continuation of this biannual pattern
until at least 2003. In order to be able to perform a time-series
analysis for the correlation between rates of PNSP and RSV
activity, local data were used as a surrogate for national data,
which were not available for the study period. Data concerning
RSV detection in respiratory samples were obtained from the
Clinical Microbiology Unit, Institute for Infectious Diseases,
University of Bern, for the period April 1998 to April 2003
(data for the spring months of 1998 were not available)
regarding the number of nasopharyngeal secretions, aspirated
using an infant mucus aspirator (Ecouen, Vygon, France), from
children aged < 5 years which gave an RSV-positive result
by direct immunofluorescence analysis (Light Diagnostics
Respiratory Panel DFA; Chemicon International, Temecula,
CA, USA).
Antibiotic consumption data
In order to estimate the contribution of antibiotic consumption
to time-trends of PNSP, consumption of oral antibiotics was
estimated based on national antibiotic sales (number of
packages) in the Swiss retail market, obtained from IHA ⁄ IMS
Health GmbH (Hergiswil, Switzerland; http://www.ihaims.
ch), for the period January 1998 to March 2003. These data
were collected continuously from manufacturers, wholesalers
and pharmacies. Completeness of data was estimated to be
> 90% for the whole country. Grouping of antibiotic classes
follows the anatomical therapeutic classes scheme of the
European Pharmaceutical Marketing Research Association
(http://www.ephmra.org). For the purpose of this study,
sales data were restricted to oral paediatric formulations in
order to estimate antibiotic consumption among small chil-
dren, who cannot swallow tablets and capsules designed for
older children and adults. Sales data were converted into
defined daily doses according to WHO guidelines (http://
www.whocc.no/atcddd, Index 2004). The number of defined
daily doses sold per 1000 children aged < 5 years per day or
month was based on the Swiss population census data for the
year 2002 (population aged < 5 years = 371 900) (http://
www.bfs.admin.ch).
Data concerning the number of antibiotic prescriptions for
upper and lower respiratory tract infections in outpatients
aged < 5 years in Switzerland were also obtained from
IHA ⁄ IMS Health GmbH. These data are collected continuously
from a representative, rotating, stratified random sample of
1052 Swiss general practitioners per year. Each practitioner
records the prescriptions for a period of 1 week per year.
Classification of acute respiratory tract infection was according
to the 10th Revision of the International Statistical Classifica-
tion of Diseases and Related Health Problems (ICD10) (http://
www3.who.int/icd/vol1htm2003/fr-icd.htm).
Statistical analysis
Time-series analyses, including auto- and cross-correlations, as
well as seasonal adjustment of data, were performed with the
SYSTAT 10 software package (SPSS Inc., Chicago, IL, USA).
Non-parametric methods were used for pairwise comparisons
(Wilcoxon signed-rank test) and correlations (Spearman rank
correlation coefficient). The study was performed according to
the guidelines on conduct of clinical research of the Ethical
Committee of the State of Bern.
RESULTS
The analysis included 2838 nasopharyngeal
swabs collected from children aged < 5 years;
1477 pneumococcal isolates were cultured from
these swabs, giving an overall colonisation rate of
52.0%. Between January 1998 and September
2003, the overall annual rate of colonisation with
PNSP increased from 15.9% to 20.1% (net trend
per year: OR 1.05; 95% CI 1.00–1.10; p 0.03).
In order to analyse seasonal trends, data were
stratified into periods of 6 months, ranging from
April to September (summer) and October to
March (winter). Rates of colonisation with PNSP
and the proportions of PNSP were higher during
winter seasons than during summer seasons, and
showed a biannual periodicity of peak antibiotic
resistance for the winter seasons (Table 1; Fig. 1).
The biannual cycles of peak rates of PNSP
correlated and were aligned with seasonal peak
RSV activity, i.e., rates of PNSP were higher in
winters with RSV activity than during the
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previous and following RSV season with low
activity (Figs 1 and 2). The prevalence of resist-
ance to erythromycin and co-trimoxazole demon-
strated no such systematic seasonal patterns (data
not shown).
Sales of paediatric oral antibiotics and antibiotic
prescriptions for acute respiratory tract infections
in children aged < 5 years showed regular seaso-
nal peaks during the winter seasons for all
antibiotic classes, but no biannual cycling patterns
were observed. Broad-spectrum penicillins were
the antibiotics consumed most frequently, fol-
lowed by oral cephalosporins and macrolides.
Between 1998 and 2002, the number of defined
daily doses sold per 1000 children aged < 5 years
per day decreased from 20.4 to 16.3 () 20.1%;
p 0.002). This reduction affected mainly the
cephalosporins and macrolides. Between 1998
and 2002, the relative proportion of oral broad-
spectrum penicillins increased from 49.0% to
58.1% (p 0.006), but that for cephalosporins
decreased from 19.2% to 17.9% (p 0.002), and
that for oral macrolides decreased from 19.3% to
13.7% (p 0.002).
Time-series analyses revealed auto-correlations
for rates of PNSP and RSV activity among
children aged < 5 years, and a cross-correlation
between these two parameters. The rate of PNSP
correlated with RSV activity (r 0.73; Spearman
rank correlation coefficient) and, to a lesser extent,
with the total number of antibiotics sold (r 0.38).
The relationship between rate of PNSP and RSV
activity persisted after seasonal adjustment (trans-
formation) of the data (r 0.64). No such correla-
tion was observed for antibiotic sales and
antibiotic prescriptions after adjustment for an-
nual seasonal patterns (transformation) (Table 2).
Time-series analyses showed no correlation
between colonisation rates with PNSP and RSV
activity, with or without adjustment for seasonal-
ity (data not shown).
DISCUSSION
The prevalence of PNSP among children aged
< 5 years showed biannual peaks during the
winter seasons, coinciding with a biannual peak
activity of RSV epidemics. To our knowledge, this
is the first report of a seasonal cycling pattern of
antibiotic resistance correlating with the epide-
miology of a viral infection. A particular strength
of this study was the availability of an ongoing
nationwide surveillance system for pneumococcal
resistance among paediatric outpatients [20]. It
would have been interesting to know whether
patients in the pneumococcal surveillance study
were concomitantly infected with RSV, but this
information was not collected during the present
study.
There are some limitations with respect to the
data for RSV activity and antibiotic consumption.
Nationwide data concerning RSV activity were
only available for 1988–1999. However, regional
data up to the year 2003 were in phase with the
older national data and could therefore be used as
a surrogate for national data [15]. Antibiotic
Table 1. Seasonal variation of nasopharyngeal colonisation with Streptococcus pneumoniae among children aged < 5 years,
1998–2003
Period
(month/year) Season RSVa
Colonisedb Colonised with PSPc Colonised with PNSPc Prevalence of PNSPd
n ⁄Total % n ⁄Total % n ⁄Total % n ⁄Total %
01–03 ⁄ 98 Winter Low 146 ⁄ 370 39.5 134 ⁄ 370 36.2 12 ⁄ 370 3.2 12 ⁄ 146 8.2
04–09 ⁄ 98 Summer – 125 ⁄ 264 47.3 106 ⁄ 264 40.1 19 ⁄ 264 7.1 19 ⁄ 125 15.2
10 ⁄ 98–03 ⁄ 99 Winter High 278 ⁄ 537 51.8 222 ⁄ 537 41.3 56 ⁄ 537 10.4 56 ⁄ 278 20.1
04–09 ⁄ 99 Summer – 122 ⁄ 216 56.5 107 ⁄ 216 49.5 15 ⁄ 216 6.9 15 ⁄ 122 12.3
10–12 ⁄ 99 Winter Low 108 ⁄ 207 52.2 94 ⁄ 207 45.4 14 ⁄ 207 6.7 14 ⁄ 108 13.0
01–03 ⁄ 01 Winter High 150 ⁄ 280 53.6 126 ⁄ 280 45.0 24 ⁄ 280 8.5 24 ⁄ 150 16.0
04–09 ⁄ 01 Summer – 78 ⁄ 167 46.7 67 ⁄ 167 40.1 11 ⁄ 167 6.5 11 ⁄ 78 14.1
10 ⁄ 01–03 ⁄ 02 Winter Low 186 ⁄ 327 56.9 162 ⁄ 327 49.2 25 ⁄ 327 7.6 25 ⁄ 186 9.5
04–09 ⁄ 02 Summer – 73 ⁄ 124 58.9 59 ⁄ 124 47.5 14 ⁄ 124 11.2 14 ⁄ 73 13.4
10 ⁄ 02–03 ⁄ 03 Winter High 155 ⁄ 249 62.2 119 ⁄ 249 47.7 36 ⁄ 249 14.4 36 ⁄ 155 19.1
04–09 ⁄ 03 Summer – 56 ⁄ 97 57.7 46 ⁄ 97 47.4 10 ⁄ 97 10.3 10 ⁄ 56 17.8
PSP, penicillin-susceptible pneumococci; PNSP, penicillin-non-susceptible pneumococci; RSV, respriratory syncytial virus.
aSeasonal activity of RSV; low refers to a winter with relatively low viral activity, and high refers to a winter with relatively high viral activity, according to the biannual
cycling pattern of RSV.
bColonised indicates the total number of samples received (Total) and the number of samples with growth of S. pneumoniae (n).
cColonised with PSP or PNSP indicates the total number of samples received (Total) and the number of samples with growth of S. pneumoniae (n) with susceptibility or reduced
susceptibility to penicillin (MIC > 0.06 mg ⁄L).
dPrevalence of PNSP indicates the percentage of pneumococci with reduced susceptibility to penicillin (MIC > 0.06 mg ⁄L) among all S. pneumoniae isolates during each
period.
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consumption among children aged < 5 years was
estimated using two data sources. Antibiotic sales
data are not equivalent to prescriptions. However,
time-trends of antibiotic sales showed regular
peaks during the winter months, indicating that
the delay between sales and prescriptions was
probably not significant. Also, for this study, the
relative time-trends were of importance rather
than the absolute magnitude of antibiotic con-
sumption. Data concerning antibiotic prescrip-
tions to children aged < 5 years for respiratory
tract infections confirmed the time-trends ob-
served for antibiotic sales data. Most importantly
for this study, neither antibiotic sales nor pre-
scription data showed the biannual pattern seen
for the prevalence of PNSP and RSV activity.
Two recent reports from Spain described sea-
sonal variations in pneumococcal resistance rates
[5,6]. However, resistance rates in Spain peaked
during the summer and winter months, and the
short observation periods did not permit analysis
of long-term trends. Antibiotic consumption is the
most important factor driving resistance, and may
therefore explain the concomitant cycles of pneu-
mococcal resistance rates and RSV activity. Anti-
biotic selection pressure is likely to be higher
during seasonal viral epidemics, since antibiotics
are (too) often prescribed for viral respiratory
tract infections [20]. Considering that RSV is the
most common cause of acute respiratory tract
infection requiring hospitalisation of infants and
young children, it is conceivable that RSV
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Fig. 1. Seasonal trends in (A) rates
of colonisation (%) of pneumococci
with reduced susceptibility to peni-
cillin (PNSP), and (B) the prevalence
of PNSP in children aged < 5 years.
Winter seasons with high or low
activity of respiratory syncytial
virus (RSV) are indicated above the
graphs. Peak prevalence and coloni-
sation rates of PNSP during the
winter seasons 1998–1999, 2000–
2001 and 2002–2003 coincide with
the biannual peak activity of RSV.
No data were available for the year
2000.
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epidemiology may measurably influence the use
of antimicrobial agents. In the present study, and
the Spanish studies, seasonal cycling of antibiotic
resistance rates was observed only for resistance
to b-lactam antibiotics, and not for resistance to
macrolides and co-trimoxazole [5,6]. b-Lactams
are by far the antibiotics consumed most fre-
quently by paediatric outpatients, and therefore
they exhibit the strongest selection pressure.
Time-series analysis showed that antibiotic
consumption could not completely explain the
biannual cycling of rates of PNSP in phase with
RSV activity. There is increasing evidence for an
interaction between respiratory viruses and bac-
teria via different pathways [21]. It has been
shown that RSV infection of respiratory epithe-
lium increases the in-vitro adherence of S. pneu-
moniae [7]. RSV epidemics may lead to increased
transmission of pneumococci through increased
colonisation density and duration, combined with
the respiratory symptoms of viral infection, such
as coughing and sneezing. In the present study,
rates of colonisation with PNSP seemed to corre-
late with RSV activity; however, this correlation
did not reach statistical significance.
Besides RSV, other respiratory viruses, such as
influenza virus and parainfluenza virus, show a
seasonal preference for the winter months. It
cannot be excluded that these viruses also influ-
ence the epidemiology of S. pneumoniae in a
similar way to that proposed for RSV [22–24].
However, national data concerning influenza
activity did not show a regular biannual cycling
activity (http://www.bag.admin.ch). A regional
surveillance programme for respiratory viruses in
east Switzerland between 1984 and 1990 showed a
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Fig. 2. Number of respiratory samples positive for respiratory syncytial virus (RSV) from children aged < 5 years, Institute
for Infectious Diseases, University of Bern, Switzerland, April 1998 to March 2003. The biannual peak epidemics
correspond with nationwide data collected between 1989 and 1999 [15].
Table 2. Correlation between time-trends of the preval-
ence of penicillin-non-susceptible pneumococci (%) among
children aged < 5 years and the seasonal activity of
respiratory syncytial virus (RSV), sales of oral paediatric
antibiotic formulations and antibiotic prescriptions for
acute respiratory tract infections (Switzerland, January
1998 to March 2003)
Prevalence of penicillin-non-susceptible
pneumococci
Raw Adjusted for seasonality
RSV activity 0.733a 0.636a
Antibiotic sales of oral
paediatric formulations
0.164b 0.224b
Antibiotic prescriptions
for acute respiratory tract
infections to children aged
< 5 years of age
0.382b ) 0.042b
ap < 0.05.
bp 0.5.
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biannual pattern in phase with RSV activity for
parainfluenza virus type 3. However, parainflu-
enza virus type 3 activity preceded the RSV
epidemics by c. 2 months (K. Schopfer, personal
communication). Also, the relative contribution of
parainfluenza virus type 3 to overall respiratory
virus activity is considerably lower than that of
RSV. Therefore, it is unlikely that parainfluenza
virus type 3 played an important role. In addition,
seasonal variation of RSV activity in Australia
showed a significant positive correlation with
invasive pneumococcal disease, but not with
influenza virus activity [4].
In summary, the present study demonstrated
seasonal variations in the prevalence of PNSP in
phase with the biannual cycling pattern of RSV
activity. Besides antibiotic selection pressure,
other viral–bacterial interactions seem to be
involved in this phenomenon. The specific nature
of such interactions remains to be characterised.
Respiratory tract viral infections are important
determinants of the spread of antibiotic resist-
ance, and must be considered in the design of
preventive strategies aimed at antimicrobial
resistance control.
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